Innocoll's IPO

Innocoll raised a round of funding on July 25, 2014. Investors include Public.

Innocoll is a global commercial stage specialty pharmaceutical company with late stage development programs targeting areas of significant unmet medical need. The company develops and manufactures a r…

Articles about Innocoll's IPO: